4E Global, S.A.P.I. de C.V.

Warning LetterOpen

MexicoFEI 3010078513Issued Oct 23, 2020

View FDA's record for FEI 3010078513

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3010078513.

Violations0

Issue DateOct 23, 2020

Product TypeDrugs

StatusOpen

Letter Details

Firm: 4E Global, S.A.P.I. de C.V.
Location: Mexico
FEI Number: 3010078513
Country: Mexico
Issue Date: October 23, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, this warning letter was issued to 4E Global, S.A.P.I. de C.V., a pharmaceutical company, on October 23, 2020. Without access to the full letter text or subject line, the specific nature of the drug manufacturing or distribution violations cannot be determined. The FDA's drug regulatory office issued this warning, indicating the violations related to pharmaceutical products subject to federal drug enforcement. Additional details regarding the specific compliance failures would require review of the complete warning letter.

4E Global, S.A.P.I. de C.V. FDA Warning Letter, October 23, 2020